The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study

11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Phyllodes tumors of the breast (PTB) are uncommon stromal-epithelial neoplasms, with the main recommended treatment being surgical removal. However, even with adequate resection, the risk of recurrence in the malignant form remains as high as 40%, and there is no recognized consensus on the most effective drugs for PTB. In the present study, an ex vivo model of malignant phyllodes and derived primary cell cultures were used to evaluate the effectiveness of a panel of different drugs, including the Bcl-2/Bcl-xL inhibitor ABT-263, salinomycin (SAL), doxorubicin (DOX), paclitaxel (TAX), vincristine (VCR), colchicine (COL) and cisplatin (CIS). ABT-263, SAL and DOX were highly effective towards phyllodes spindle cells when assessed in the ex vivo model, contributing to ~98% tumor cell death. Furthermore, ABT-263 was highly selective for tumor cells in this system, and exhibited little toxic effect on adjacent normal epithelial cells. Furthermore, consistent with findings in the ex vivo model, ABT-263 was significantly less toxic towards MCF 10A non-tumorigenic breast epithelial cells compared with SAL and DOX. A conditional reprogramming strategy was subsequently used, involving Rho kinase inhibition, to successfully generate primary phyllodes tumor cells that could be cultured for several passages. The primary cells were sensitive to DOX with an IC50 of 0.40±0.07 μM in a standard viability assay and the preliminary results were obtained indicating sensitivity to ABT-263 and SAL. The present study demonstrated the feasibility of using explants and primary cells for drug discovery, selectively targeting PTB cells.

References Powered by Scopus

Microtubules as a target for anticancer drugs

3892Citations
N/AReaders
Get full text

The NCI60 human tumour cell line anticancer drug screen

2214Citations
N/AReaders
Get full text

The essence of senescence

1681Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Salinomycin as a potent anticancer stem cell agent: State of the art and future directions

48Citations
N/AReaders
Get full text

Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel

14Citations
N/AReaders
Get full text

Culture and application of conditionally reprogrammed primary tumor cells

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Urbaniak, A., Jousheghany, F., Yuan, Y., Pina-Oviedo, S., Huczynski, A., Delgado, M., … Chambers, T. C. (2019). The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study. Oncology Letters, 18(5), 5097–5106. https://doi.org/10.3892/ol.2019.10823

Readers over time

‘19‘20‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Professor / Associate Prof. 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

33%

Pharmacology, Toxicology and Pharmaceut... 2

33%

Chemistry 2

33%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 26

Save time finding and organizing research with Mendeley

Sign up for free
0